ImPact Biotech Presents Updated Data from Phase 1 Trial of Padeliporfin VTP in LA-PDAC and Phase 3 ENLIGHTED Trial in LG-UTUC at ASCO 2026

Source · https://www.globenewswire.com/news-release/2026/05/30/3303885/0/en/impact-biotech-presents-updated-data-from-phase-1-trial-of-padeliporfin-vtp-in-la-pdac-and-phase-3-enlighted-trial-in-lg-utuc-at-asco-2026.html

Read source

ImPact Biotech Presents Updated Data from Phase 1 Trial of Padeliporfin VTP in LA-PDAC and Phase 3 ENLIGHTED Trial in LG-UTUC at ASCO 2026

Story key points

0 claims · impact-rated

What matters in this story

No key-points head found for this article.

Ticker attribution

Model heads

Sentiment in this article

No ticker sentiment head found.

Relationships in this article

No ticker relationship head found.

Impact vectors

0 dimensions · 9 clusters

Analytical profile by cluster

Macro Sensitivity+0.000
Sector Rotation+0.000

News Impact Screener — Catch market-moving news before the crowd

ImPact Biotech Presents Updated Data from Phase 1 Trial of Padeliporfin VTP in LA-PDAC and Phase 3 ENLIGHTED Trial in LG-UTUC at ASCO 2026

What matters in this story

Sentiment in this article

Relationships in this article

Analytical profile by cluster

ImPact Biotech Presents Updated Data from Phase 1 Trial of Padeliporfin VTP in LA-PDAC and Phase 3 ENLIGHTED Trial in LG-UTUC at ASCO 2026

What matters in this story

Sentiment in this article

Relationships in this article

Analytical profile by cluster

Top impact dimensions

Most positively impacted

Most negatively impacted